UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2024
Commission File Number: 001-41842
Abivax SA
(Translation of registrant’s name into English)
7-11 boulevard Haussmann
75009 Paris, France
+33 (0) 1 53 83 08 41
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
On May 30, 2024, Abivax SA (the “Company”) held its ordinary and extraordinary general meeting of shareholders on May 30, 2024. The final results of each of the agenda items submitted to a vote of the shareholders are as follows:
Number of shares with voting rights |
61 012 501 | |||
Total number of votes |
68 032 059 | |||
Number of shareholders present, represented or voting by post |
132 | |||
Number of shares present, represented or voting by post |
49 815 120 | |||
Number of votes present, represented or voting by post |
55 747 104 | |||
Participation rate |
81.65 | % |
Ordinary General Shareholders’ Meeting |
For | Against | Abstain | |||||||||||||||||||||||
Votes | % | Votes | % | Votes | % | |||||||||||||||||||||
1. |
Approval of the Company’s financial statements for the financial year ended 31 December 2023 | 55 730 237 | 99.999 | % | 494 | 0.001 | % | 16 373 | 0.029 | % | ||||||||||||||||
2. |
Approval of the Company’s consolidated financial statements for the financial year ended 31 December 2023 | 55 730 237 | 99.999 | % | 494 | 0.001 | % | 16 373 | 0.029 | % | ||||||||||||||||
3. |
Allocation of the income for the financial year ended 31 December 2023 | 55 746 610 | 99.999 | % | 494 | 0.001 | % | 0 | 0.000 | % | ||||||||||||||||
4. |
Approval of the agreements referred to Articles L. 225-38 et seq. of the French Commercial Code (Code de commerce) | 44 083 418 | 79.078 | % | 11 663 486 | 20.922 | % | 200 | 0.001 | % | ||||||||||||||||
5. |
Ratification of the cooptation of a Director (Troy Ignelzi) | 55 707 725 | 99.930 | % | 39 179 | 0.070 | % | 200 | 0.001 | % | ||||||||||||||||
6. |
Ratification of the cooptation of a Director (June (Lee) Kim) | 55 707 725 | 99.930 | % | 39 179 | 0.070 | % | 200 | 0.001 | % | ||||||||||||||||
7. |
Ratification of the cooptation of a Director (Camilla Soenderby) | 55 746 324 | 99.999 | % | 580 | 0.001 | % | 200 | 0.001 | % | ||||||||||||||||
8. |
Approval of the compensation items mentioned in Article L. 22-10-9 I of the French Commercial Code, pursuant to Article L. 22-10-34 of the French Commercial Code | 54 504 460 | 97.771 | % | 1 242 444 | 2.229 | % | 200 | 0.001 | % | ||||||||||||||||
9. |
Approval of the compensation items paid during, or allocated for, the financial year 2023 to Ms. Corinna zur Bonsen-Thomas as Chair of the Board of Directors by interim | 55 594 011 | 99.726 | % | 152 893 | 0.274 | % | 200 | 0.001 | % | ||||||||||||||||
10. |
Approval of the compensation items paid during, or allocated for, the financial year 2023 to Mr. Marc de Garidel as Chairman of the Board of Directors and Chief Executive Officer | 44 137 875 | 79.175 | % | 11 609 029 | 20.825 | % | 200 | 0.001 | % | ||||||||||||||||
11. |
Approval of the compensation items paid during, or allocated for, the financial year 2023 to Mr. Hartmut Ehrlich as Chief Executive Officer | 44 056 505 | 79.030 | % | 11 690 399 | 20.970 | % | 200 | 0.001 | % |
Ordinary General Shareholders’ Meeting |
For | Against | Abstain | |||||||||||||||||||||||
Votes | % | Votes | % | Votes | % | |||||||||||||||||||||
12. |
Approval of the information on corporate officers’ compensation included in the corporate governance report and referred to in Article L.22-10-9 I. of the French Commercial Code | 54 655 224 | 98.042 | % | 1 091 680 | 1.958 | % | 200 | 0.001 | % | ||||||||||||||||
13. |
Approval of the compensation policy applicable to the Chairman of the Board of Directors | 55 744 775 | 99.996 | % | 2 129 | 0.004 | % | 200 | 0.001 | % | ||||||||||||||||
14. |
Approval of the compensation policy applicable to the Chief Executive Officer | 44 256 935 | 79.389 | % | 11 489 969 | 20.611 | % | 200 | 0.001 | % | ||||||||||||||||
15. |
Approval of the compensation policy applicable to the Board members | 55 594 011 | 99.726 | % | 152 893 | 0.274 | % | 200 | 0.001 | % | ||||||||||||||||
16. |
Authorization to be granted to the Board to purchase the Company’s own shares | 44 593 043 | 79.992 | % | 11 153 861 | 20.008 | % | 200 | 0.001 | % | ||||||||||||||||
Extraordinary General Shareholders’ Meeting |
For | Against | Abstain | |||||||||||||||||||||||
Votes | % | Votes | % | Votes | % | |||||||||||||||||||||
17. |
Authorization to the Board of Directors to reduce share capital by cancelling treasury shares | 55 444 282 | 99.457 | % | 302 622 | 0.543 | % | 200 | 0.001 | % | ||||||||||||||||
18. |
Delegation of authority to the Board of Directors to carry out a capital increase by issuing shares, equity securities giving access to other equity securities or giving the right to the allocation of debt securities and/or securities giving access to equity securities, maintaining preferential subscription rights | 44 183 811 | 79.258 | % | 11 563 093 | 20.742 | % | 200 | 0.001 | % | ||||||||||||||||
19. |
Delegation of authority to the Board of Directors to carry out a capital increase by issuing shares, equity securities giving access to other equity securities or giving the right to the allocation of debt securities and/or securities giving access to equity securities, with cancellation of the preferential subscription rights by way of an offer to the public, and with the ability to confer a right of priority | 44 034 819 | 78991 | % | 11 712 085 | 21.009 | % | 200 | 0.001 | % | ||||||||||||||||
20. |
Delegation of authority to the Board of Directors to carry out a capital increase by issuing shares, equity securities giving access to other equity securities or giving the right to the allocation of debt securities and/or securities giving access to equity securities, with cancellation of the preferential subscription rights in favor of a specific category of persons | 44 035 900 | 78.993 | % | 11 711 004 | 21.007 | % | 200 | 0.001 | % |
Extraordinary General Shareholders’ Meeting |
For | Against | Abstain | |||||||||||||||||||||||
Votes | % | Votes | % | Votes | % | |||||||||||||||||||||
21. |
Delegation of authority to the Board of Directors to carry out a capital increase, within the limit of 20% of the share capital per year, by issuing shares, equity securities conferring access to other equity securities or conferring the right to an allotment of debt securities and/or securities conferring access to equity securities, with cancellation of the preferential subscription rights by way of an offer to qualified investors or a restricted group of investors, within the meaning of Article L. 411-2, paragraph II, of the French Monetary and Financial Code (Code monétaire et financier) | 44 629 521 | 80.057 | % | 11 117 383 | 19.943 | % | 200 | 0.001 | % | ||||||||||||||||
22. |
Authorization to be granted to the Board of Directors in accordance with Articles L. 22-10-52, paragraph 2, and R. 22-10-32 of the French Commercial Code to set the issue price of the shares, equity securities conferring access to other equity securities or conferring the right to an allotment of debt securities and/or securities conferring access to equity securities, with cancellation of the preferential subscription rights, for the delegations of authority set forth in the 19th and 21st resolutions | 44 223 534 | 79.329 | % | 11 523 370 | 20.671 | % | 200 | 0.001 | % | ||||||||||||||||
23. |
Delegation of authority to the Board of Directors to carry out a capital increase by issuing shares, equity securities conferring access to other equity securities or conferring the right to an allotment of debt securities and/or securities conferring access to equity securities, with cancellation of the preferential subscription rights in favor of certain categories of investors within the framework of an equity financing agreement in the United States stock market known as an “At-The-Market” or “ATM Program” | 44 074 499 | 79.062 | % | 11 672 405 | 20.938 | % | 200 | 0.001 | % | ||||||||||||||||
24. |
Delegation of authority to the Board of Directors to increase the number of shares to be issued in the event of a capital increase with or without preferential subscription rights | 44 309 207 | 79.483 | % | 11 437 697 | 20.517 | % | 200 | 0.001 | % | ||||||||||||||||
25. |
Delegation of authority to the Board of Directors to increase capital by capitalizing premiums, reserves, profits or other items | 55 626 350 | 99.784 | % | 120 554 | 0.216 | % | 200 | 0.001 | % |
Extraordinary General Shareholders’ Meeting |
For | Against | Abstain | |||||||||||||||||||||||
Votes | % | Votes | % | Votes | % | |||||||||||||||||||||
26. |
Delegation of authority to the Board of Directors to issue shares and securities leading to a capital increase in consideration of non-cash contributions | 44 073 640 | 79.060 | % | 11 673 264 | 20.940 | % | 200 | 0.001 | % | ||||||||||||||||
27. |
Delegation of authority to the Board of Directors to issue shares and securities entailing a capital increase in the event of a public exchange offer initiated by the Company | 44 035 041 | 78.991 | % | 11 711 863 | 21.009 | % | 200 | 0.001 | % | ||||||||||||||||
28. |
Setting of the overall limits on the amount of the issues carried out pursuant to the delegations granted | 55 550 917 | 99.648 | % | 195 987 | 0.352 | % | 200 | 0.001 | % | ||||||||||||||||
29. |
Authorization to the Board of Directors to grant share subscription and/or purchase options (“Options”), with cancellation of the shareholders’ preferential subscription rights in favor of a specific category of persons | 44 009 664 | 78.945 | % | 11 737 240 | 21.055 | % | 200 | 0.001 | % | ||||||||||||||||
30. |
Delegation of authority to the Board of Directors to issue and allot ordinary share warrants (“Warrants”), with cancellation of the shareholders’ preferential subscription rights in favor of a specific category of persons | 44 049 263 | 79.017 | % | 11 697 641 | 20.983 | % | 200 | 0.001 | % | ||||||||||||||||
31. |
Authorization to the Board of Directors to allot free shares, whether existing or to be issued (“Free Shares”), with cancellation of the shareholders’ preferential subscription rights in favor of a specific category of persons | 44 165 912 | 79.226 | % | 11 580 992 | 20.774 | % | 200 | 0.001 | % | ||||||||||||||||
32. |
Setting of the overall limits on the amount of the issues carried out pursuant to the authorizations to grant Options and Free Shares and the delegations of authority in order to issue Warrants | 55 704 647 | 99.924 | % | 42 257 | 0.076 | % | 200 | 0.001 | % | ||||||||||||||||
33. |
Delegation of authority to the Board of Directors to carry out a capital increase by issuing shares or securities conferring access to the Company’s capital restricted to members of a company savings plan, with cancellation of the shareholders’ preferential subscription rights in favor thereof | 32 655 576 | 58.578 | % | 23 091 328 | 41.422 | % | 200 | 0.001 | % |
Ordinary General Shareholders’ Meeting |
For | Against | Abstain | |||||||||||||||||||||||
Votes | % | Votes | % | Votes | % | |||||||||||||||||||||
34. |
Powers for formalities | 55 746 410 | 99.999 | % | 494 | 0.001 | % | 200 | 0.001 | % |
Press Release
On June 4, 2024, the Company published a press release entitled “Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting.” A copy of the press release is furnished as Exhibit 99.1 to this Report on Form 6-K and is incorporated herein by reference.
Exhibit Index
Exhibit 99.1 | Press Release, dated June 4, 2024 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Abivax SA | ||||||
(Registrant) | ||||||
Date: June 4, 2024 | /s/ Marc de Garidel | |||||
Marc de Garidel | ||||||
Chief Executive Officer |